This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Similar Posts
Early Alert: Trividia Health Issues Correction for TRUE METRIX Blood Glucose Monitoring Systems
Trividia recommends that device users who receive an E-5 error code and are experiencing symptoms of high glucose should seek medical care immediatelyBulk Drug Substances Used in Compounding
Compounders sometimes produce drugs using bulk drug substances or active pharmaceutical ingredients. Because compounding from these substances presents risks to patients, sections 503A and 503B of the FD&C Act place limits on the bulk drug substances that can be used in compounding.FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
The U.S. Food and Drug Administration today announced the issuance of 30 warning letters to telehealth companies for making false and misleading claims regarding compounded GLP-1 products offered on their websites.Guidance Documents for Rare Disease Drug Development
Guidance Documents for Rare Disease Drug DevelopmentZydus Lifesciences Limited – 9/5/2025
Zydus Lifesciences Limited – 9/5/2025. Country: India. Record Type: 483Guangxi Yulin Pharmaceutical Group Co. Ltd. – 710422 – 09/30/2025
CGMP/Finished Pharmaceuticals/Adulterated